ESHRE立场文件:配子捐赠者国际后代数量限制
ESHRE发布立场文件,建议在欧盟范围内限制每名配子捐赠者的家庭数,从50个家庭逐步降至最多15个或更低,并建立欧盟捐赠者登记系统监测合规。该建议基于多学科专家工作组,采用预防性原则,因大供体同胞群心理社会影响证据有限。
要点
- 建议欧盟统一限制每捐赠者家庭数,起始50个家庭,逐步降至≤15个。
- 应建立欧盟捐赠者登记系统,配子库须执行限制,捐赠者须申报所有既往捐赠。
- 国家更低限制应保留,捐赠者可设更低个人限制,家庭数按潜在活产计。
核心结论
- ESHRE建议引入欧盟范围内每配子捐赠者家庭数限制,从50个家庭逐步降至最多15个或更低,并以欧盟登记系统监测合规。
主要发现
- ESHRE认为确定限制时应最高优先考虑供体来源个体的福祉,同时平衡预期父母的福祉,限制应针对家庭数而非个体子女数。
- 建议分阶段引入,起始每捐赠者50个家庭,降至最多15个或更低,并对首次捐赠后向新家庭分配配子设置20年上限。
- 国家限制更低时应予维持,捐赠者可设定更低的个人限制,合规通过欧盟或国家登记系统监测。
- 配子库(包括向欧盟出口的非欧盟库)有义务执行限制,捐赠者须申报所有既往捐赠,家庭数按潜在活产计除非确认 otherwise。
关键数值与推荐
- 建议每捐赠者家庭数限制:起始50个家庭,逐步降至最多15个或更低。
- 首次捐赠后向新家庭分配配子的时间上限为20年。
- 收到45份利益相关者审查表,来自代表供体来源个体、家庭、患者、国家生育学会、研究者、专业人士和配子库的组织。
临床怎么用
- 临床机构应遵循欧盟统一限制,配子库须执行并核实捐赠者申报,优先采用欧盟登记系统监测合规,国家更低限制仍适用。
局限性
- 关于大供体同胞群心理社会影响的证据基础较小且仍在发展,明确危害证据有限。
- 关于供体来源个体、捐赠者和接受者对后代限制偏好的研究稀缺且无定论,建议采取预防性原则,15个家庭限制应在过渡期根据新知识审查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How should the number of offspring per gamete donor be regulated at an international level? SUMMARY ANSWER: The European Society of Human Reproduction and Embryology (ESHRE) recommends introducing a European Union (EU)-wide limit on the number of families per gamete donor, starting at 50 families and gradually reducing it to a maximum of 15 families or lower, supported by an EU-wide donor registry to monitor compliance. WHAT IS KNOWN ALREADY: Most European countries impose national limits on the number of offspring or families per donor, but these limits vary widely and are not always enforced. Cross-border movement of patients and the export of donor gametes between countries mean that large donor sibling groups can still emerge despite these restrictions. What matters to donor-conceived people is the total number of donor siblings, regardless of which country they are in, making a transnational limit the only relevant mechanism that can address this issue. STUDY DESIGN, SIZE, DURATION: This position paper sets out principles relevant to international donor offspring limits and the position and policy recommendations of ESHRE, focusing on the EU level. PARTICIPANTS/MATERIALS, SETTING, METHODS: This ESHRE position paper was developed by a multidisciplinary expert working group. Recommendations are supported by data from the literature, where available. The first version was published for stakeholder review in November 2025, with 45 completed review forms received from organizations representing donor-conceived people, families built through donor conception and infertility patients, national fertility societies, researchers, professionals from different disciplines, and gamete banks. The paper was then revised on the basis of the stakeholder review. MAIN RESULTS AND THE ROLE OF CHANCE: ESHRE considers that the wellbeing of donor-conceived people should have the highest priority when determining limits, while also balancing the wellbeing of prospective parents. Limits should be set for the number of families rather than individual children. ESHRE proposes a phased introduction starting at 50 families per donor, being reduced to a maximum of 15 families or lower, alongside a 20-year cap on distributing gametes to new families after the first donation. National limits should still be upheld where they are lower, and donors should be able to set their own lower personal limit. Compliance should be monitored through an EU-wide donor registry or, failing that, national registries, with gamete banks (including non-EU banks exporting into the EU) obliged to enforce the limit, donors required to declare all previous donations, and families counted as potential live births unless confirmed otherwise. LIMITATIONS, REASONS FOR CAUTION: The evidence base on the psychosocial impact of large donor sibling groups is small and developing, and definitive evidence of harm is limited. Research on the preferences of donor-conceived people, donors, and recipients regarding offspring limits is scarce and inconclusive. These recommendations therefore take a precautionary approach, and the proposed 15-family limit should be reviewed in light of developing knowledge during the transition period. WIDER IMPLICATIONS OF THE FINDINGS: An EU-wide limit would represent a feasible first step towards an international limit. An EU-wide donor registry could potentially serve secondary purposes such as supporting tracing in case of the diagnosis of a serious genetic condition and giving access to information to donors and donor-conceived people. FUNDING: Support for the working group was provided by ESHRE. DISCLOSURES: L.F. and C.C.-J. report travel support from ESHRE. D.P.B. reports speakers' fees from Merck, Ferring, Gedeon Richter and MSD, travel support from ESHRE, and a position as the president of the Croatian Society for Gynaecological Endocrinology and Human Reproduction. A.A. reports speakers' fees from Merck Healthcare KGaA and Ferring, travel support from ESHRE, passive shareholder interest in Inception Midco 1. S.à r.l., membership in a subgroup of the European Medical Devices Coordination Group, and a position as vice chair of the EXPAMED panel on obstetrics, gynaecology and reproductive medicine. G.N. reports speakers' fees from Gedeon-Richter and Organon, travel support from ESHRE, and a position as past chairman and member of the Executive Committee of the Bulgarian Association for Human Reproductive Embryology. P.T. reports speakers' fees and travel support from Ferring and Gedeon Richter and a position as a board member on the Arbeitskreis donogene Insemination. J.K.-B. reports speakers' fees from Ferring, IBSA, Merck and CooperSurgical, travel support from Merck and ESHRE, an associate editor position for the journal Andrology, and a position as chair of the scientific advisory committee of the Association for Reproductive and Clinical Scientists (ARCS). The remaining authors (J.T. and N.V.) have nothing to declare. TRIAL REGISTRATION NUMBER: n/a.
引用
- Frith L, Tassot J, Ahlstrom A, et al. ESHRE position paper: international limits on the number of offspring per gamete donor. Hum Reprod. 2026. PMID: 42415539. doi:10.1093/humrep/deag108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。